News
VPHIF
0.0001
NaN%
--
Weekly Report: what happened at VPHIF last week (0908-0912)?
Weekly Report · 09/15 10:40
Weekly Report: what happened at VPHIF last week (0901-0905)?
Weekly Report · 09/08 10:42
Weekly Report: what happened at VPHIF last week (0825-0829)?
Weekly Report · 09/01 10:38
Weekly Report: what happened at VPHIF last week (0818-0822)?
Weekly Report · 08/25 10:46
Weekly Report: what happened at VPHIF last week (0811-0815)?
Weekly Report · 08/18 10:40
Weekly Report: what happened at VPHIF last week (0804-0808)?
Weekly Report · 08/11 10:46
Weekly Report: what happened at VPHIF last week (0728-0801)?
Weekly Report · 08/04 10:48
Weekly Report: what happened at VPHIF last week (0721-0725)?
Weekly Report · 07/28 10:49
Weekly Report: what happened at VPHIF last week (0714-0718)?
Weekly Report · 07/21 10:41
Weekly Report: what happened at VPHIF last week (0707-0711)?
Weekly Report · 07/14 10:48
Weekly Report: what happened at VPHIF last week (0630-0704)?
Weekly Report · 07/07 10:42
Weekly Report: what happened at VPHIF last week (0623-0627)?
Weekly Report · 06/30 10:47
Weekly Report: what happened at VPHIF last week (0616-0620)?
Weekly Report · 06/23 10:41
Weekly Report: what happened at VPHIF last week (0609-0613)?
Weekly Report · 06/16 10:46
Weekly Report: what happened at VPHIF last week (0602-0606)?
Weekly Report · 06/09 10:47
Weekly Report: what happened at VPHIF last week (0526-0530)?
Weekly Report · 06/02 10:53
Weekly Report: what happened at VPHIF last week (0519-0523)?
Weekly Report · 05/26 10:53
Weekly Report: what happened at VPHIF last week (0512-0516)?
Weekly Report · 05/19 10:45
Weekly Report: what happened at VPHIF last week (0505-0509)?
Weekly Report · 05/12 10:46
Weekly Report: what happened at VPHIF last week (0428-0502)?
Weekly Report · 05/05 10:48
More
Webull provides a variety of real-time VPHIF stock news. You can receive the latest news about Valeo Pharma through multiple platforms. This information may help you make smarter investment decisions.
About VPHIF
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.